India
· Delayed Price · Currency is INR Suven Pharmaceuticals Statistics
Total Valuation
NSE:SUVENPHAR has a market cap or net worth of INR 312.21 billion. The enterprise value is 306.55 billion.
| Market Cap | 312.21B |
| Enterprise Value | 306.55B |
Important Dates
The last earnings date was Wednesday, February 12, 2025.
| Earnings Date | Feb 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NSE:SUVENPHAR has 254.56 million shares outstanding. The number of shares has increased by 0.37% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 254.56M |
| Shares Change (YoY) | +0.37% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 2.23% |
| Owned by Institutions (%) | 24.80% |
| Float | 95.78M |
Valuation Ratios
The trailing PE ratio is 112.18 and the forward PE ratio is 64.36.
| PE Ratio | 112.18 |
| Forward PE | 64.36 |
| PS Ratio | 29.78 |
| PB Ratio | 15.78 |
| P/TBV Ratio | 18.29 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 109.78 |
| EV / Sales | 29.24 |
| EV / EBITDA | 83.73 |
| EV / EBIT | 98.78 |
| EV / FCF | n/a |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | n/a |
| Interest Coverage | 34.86 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | 9.50% |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | 8.79M |
| Profits Per Employee | 2.34M |
| Employee Count | 1,193 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +82.47% in the last 52 weeks. The beta is 1.34, so NSE:SUVENPHAR's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +82.47% |
| 50-Day Moving Average | 1,109.19 |
| 200-Day Moving Average | 1,043.45 |
| Relative Strength Index (RSI) | 64.29 |
| Average Volume (20 Days) | 691,303 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, NSE:SUVENPHAR had revenue of INR 10.48 billion and earned 2.79 billion in profits. Earnings per share was 10.93.
| Revenue | 10.48B |
| Gross Profit | 6.58B |
| Operating Income | 3.10B |
| Pretax Income | 3.63B |
| Net Income | 2.79B |
| EBITDA | 3.66B |
| EBIT | 3.10B |
| Earnings Per Share (EPS) | 10.93 |
Balance Sheet
The company has 6.56 billion in cash and 394.60 million in debt, giving a net cash position of 6.16 billion or 24.21 per share.
| Cash & Cash Equivalents | 6.56B |
| Total Debt | 394.60M |
| Net Cash | 6.16B |
| Net Cash Per Share | 24.21 |
| Equity (Book Value) | 20.28B |
| Book Value Per Share | 77.73 |
| Working Capital | n/a |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 62.78%, with operating and profit margins of 29.60% and 26.63%.
| Gross Margin | 62.78% |
| Operating Margin | 29.60% |
| Pretax Margin | 34.64% |
| Profit Margin | 26.63% |
| EBITDA Margin | 34.92% |
| EBIT Margin | 29.60% |
| FCF Margin | n/a |
Dividends & Yields
NSE:SUVENPHAR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.37% |
| Shareholder Yield | -0.37% |
| Earnings Yield | 0.89% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on September 25, 2020. It was a forward split with a ratio of 2.
| Last Split Date | Sep 25, 2020 |
| Split Type | Forward |
| Split Ratio | 2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |